Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc

Registered Charity 3104


Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.


ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (Word, 198 KB)
Why become a member?

Therapies For Fibromyalgia May Be On The Horizon

Thursday 27 September 2018


From Health Europa:



Therapies for fibromyalgia may be on the horizon

26th September 2018
© Pan European Networks Ltd

Researchers at Karolinska Institutet, Sweden, and Harvard University, USA, have made a groundbreaking step towards finding new therapies for fibromyalgia.

Therapies for fibromyalgia have been difficult to come by; however, researchers have discovered that the activation of glial cells causes inflammation in the brain of fibromyalgia patients, therefore paving the way for new therapies.

Difficulties of developing therapies for fibromyalgia

Fibromyalgia is a chronic disorder that causes muscle pain, severe fatigue, insomnia and cognitive difficulties, with patients experiencing symptoms of pain and tenderness throughout the body. Unfortunately for sufferers, the causes of the difficult-to-treat pain disorder are predominantly unknown.

“The findings open the way for the development of completely new therapies for this currently difficult-to-treat condition,” says Professor Eva Kosek from the Department of Clinical Neuroscience, Karolinska Institutet.

Nevertheless, using PET brain imaging, researchers at Karolinska and Harvard, have now shown that glial cells, the immune cells of the central nervous system, are activated in the brains of patients with fibromyalgia. Therefore, opening the way for new therapies.


Full article…


Arrow right

More Fibromyalgia News



blog comments powered by Disqus
Previous Previous Page